-
5
Apr
2012
Meredith Hawkins to Receive Top Award from American Federation for Medical Research
Meredith Hawkins, M.D., professor of medicine and director of the Global Diabetes Initiative at Albert Einstein College of Medicine of Yeshiva University, will receive the American Federation for Medical Research’s (AFMR) highest honor for medical research, the Outstanding Investigator Award. The prestigious prize is given annually to one exceptional investigator aged 45 or younger for excellence in biomedical research.
[caption id="" align="alignleft" width="125" caption="Dr. Meredith Hawkins"]
[/caption]
Hawkins was selected for her diabetes research, which examines the liver’s role in glucose regulation and production, and how elevated fatty acids contribute to insulin resistance and inflammation in humans with glucose intolerance or obesity. While insulin’s role in regulating blood glucose has been widely studied, Hawkins’ group did pioneering studies showing that, in susceptible individuals, the liver fails to sense an increase in blood glucose—findings that may lead to novel diabetes drugs. They also study malnutrition diabetes, a poorly understood form of the disease that particularly affects the developing world.
“Dr. Hawkins is an innovative clinical scientist, committed mentor, prolific member of our Diabetes Research Center and an international force through her leadership of Einstein’s Global Diabetes Initiative,” said Harry Shamoon, M.D., director of the Einstein-Montefiore Institute for Clinical and Translational Research and one of her former research mentors. “This is well-deserved recognition for Dr. Hawkins’ stellar track record as a clinical and translational investigator.”
A previous recipient of AFMR’s Junior Physician-Investigator Award, Hawkins will present an overview of her work at AFMR’s Henry Christian Awards dinner on April 17, 2012. She will then accept the award at the Translational Science 2012 meeting on April 19, 2012 in Washington, DC.
“I am honored and thankful to receive this award,” said Hawkins. “As the rate of diabetes and its serious health complications continues to rise worldwide, support and validation from organizations like the AFMR are necessary to help investigators like me continue to identify and develop effective and practical treatments.” Dr. Hawkins is also an attending physician in endocrinology at Montefiore Medical Center, the University Hospital for Einstein.
Established in 1940 as the American Federation for Clinical Research, the AFMR is an international organization that bridges basic and patient-oriented research in multiple medical disciplines. Their broad medical sciences constituency includes basic, translational and clinical researchers. none
[/caption]
Hawkins was selected for her diabetes research, which examines the liver’s role in glucose regulation and production, and how elevated fatty acids contribute to insulin resistance and inflammation in humans with glucose intolerance or obesity. While insulin’s role in regulating blood glucose has been widely studied, Hawkins’ group did pioneering studies showing that, in susceptible individuals, the liver fails to sense an increase in blood glucose—findings that may lead to novel diabetes drugs. They also study malnutrition diabetes, a poorly understood form of the disease that particularly affects the developing world.
“Dr. Hawkins is an innovative clinical scientist, committed mentor, prolific member of our Diabetes Research Center and an international force through her leadership of Einstein’s Global Diabetes Initiative,” said Harry Shamoon, M.D., director of the Einstein-Montefiore Institute for Clinical and Translational Research and one of her former research mentors. “This is well-deserved recognition for Dr. Hawkins’ stellar track record as a clinical and translational investigator.”
A previous recipient of AFMR’s Junior Physician-Investigator Award, Hawkins will present an overview of her work at AFMR’s Henry Christian Awards dinner on April 17, 2012. She will then accept the award at the Translational Science 2012 meeting on April 19, 2012 in Washington, DC.
“I am honored and thankful to receive this award,” said Hawkins. “As the rate of diabetes and its serious health complications continues to rise worldwide, support and validation from organizations like the AFMR are necessary to help investigators like me continue to identify and develop effective and practical treatments.” Dr. Hawkins is also an attending physician in endocrinology at Montefiore Medical Center, the University Hospital for Einstein.
Established in 1940 as the American Federation for Clinical Research, the AFMR is an international organization that bridges basic and patient-oriented research in multiple medical disciplines. Their broad medical sciences constituency includes basic, translational and clinical researchers. none






“Einstein’s faculty members have a wealth of unexpected stories – and varied perspectives on pressing medical issues – waiting to be shared,” said Gordon Earle, associate dean of the Philip and Rita Rosen Department of Communications and Public Affairs. “Many of them are also gifted writers with sharp points of view. We decided it was the right time to create an outlet for them.”
“The Doctor’s Tablet” will tackle a range of subjects, from doctors’ personal experiences in clinical practice to considered viewpoints on medical questions of the day. Beyond the world of statistics, paperwork and policy, daily interactions in medicine are usually quite personal – for doctor and patient alike. “The Doctor’s Tablet” will reflect this reality, offering thoughtful contributions to the ongoing conversation on the state of healthcare and translational research and how both intersect with people’s lives.
“We expect ‘The Doctor’s Tablet’ to be thought-provoking, but we’re also hoping it will spark vigorous debate and discussion,” said Paul Moniz, managing director of communications and marketing, who will help oversee the blog along with social media manager, David Flores. “In an open academic environment such as Einstein’s, frank and honest discourse is encouraged and we hope readers will jump in and engage with the authors – and each other,” Moniz added.
Visit “
[/caption]
This Einstein ethos is no more evident than in the recent trip to Peru that Ms. Long undertook in conjunction with